Company page

Solid Biosciences Inc.

Solid Biosciences Inc. is a public company traded under the ticker SLDB in the American market, with a market capitalization of approximately $820 million. The company focuses on developing innovative therapies for Duchenne muscular dystrophy (DMD) and other serious genetic diseases. Solid Biosciences aims to advance its scientific research and product pipeline to address unmet medical needs in these areas.